Posts by Eric Macklin, PhD
-
Design and Statistical Innovations in the Healey ALS Platform Trial
Sabrina Paganoni, MD, PhD, Eric A. Macklin, PhD, and colleagues explain the statistical approaches used in the Healey ALS Platform Trial to integrate functional and survival outcomes and account for potential differences in the outcomes of participants within the shared control group.
-
Diet-monitoring App Can Help Slow the Progression of ALS
Patients living with ALS can maintain or improve their body weight more effectively by using a diet monitoring app than by receiving standard care, according to the results of a new clinical trial.
Biography
Eric Macklin, PhD, is an assistant in biostatistics at Massachusetts General Hospital and a biostatistician and an instructor in Neurology at Harvard Medical School.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.